- This event has passed.
Simulation from ODE-based population PK/PD and systems pharmacology models in R using mrgsolve
June 2, 2018 @ 8:30 am - 4:30 pm
Montreux, Switzerland (PAGE satellite meeting, Eurotel – Club Salon, 1820 Montreux)
Instructors: Matthew Riggs, Ph.D. and Kyle Baron, Pharm.D., Ph.D.
Workshop summary: We will provide a guided hands-on experience in the use of the R package mrgsolve. mrgsolve is a free, open source, validated R package to facilitate simulation from hierarchical, ODE-based PK/PD and systems pharmacology models frequently employed in pharmaceutical research and development programs. You will code, execute, and summarize PK, PK/PD and systems pharmacology model simulations using mrgsolve and R. Through many examples, you will learn to implement model-based simulations to help address questions at a variety of stages of a development program.
Full Price: $600
Academia/government attendees: $300
Materials Provided by Metrum: Metworx user login (with 1-week access post-workshop), course slides, data and code for all examples.
Requirements for Attendees: Knowledge and experience in PKPD modeling and simulation, nonlinear mixed effects modeling and the use of R (or S-PLUS).
Participants should bring a laptop that meets the following requirements:
– Browser: Chrome, Firefox, or Safari
– Internet access via Wi-Fi
Upon completion of this workshop, participants should be able to:
- Code ODE-based models in mrgsolve format
- Work with mrgsolve model objects and simulation output
- Create simulations of varying complexity, including sensitivity analyses, using event objects and simulation data sets
- Create population simulations that incorporate uncertainty in the parameters to address questions in drug development
- Assign login credentials and check out course materials
- Hands-on Introduction to mrgsolve (morning coffee break included)
- Installation overview
- Where to get mrgsolve
- Basic introduction to mrgsolve
- Code a very basic model
- Load and work with model object
- Simulation with event objects and data sets
- Handling simulated output
- Models with covariates and population elements
- Updating the model object and sensitivity analyses
- Installation overview
- Applied simulation with PK/PD, PBPK, and QSP models (afternoon coffee break included)
- Simulation from a population model with and without uncertainty in the parameters using a PK/PD model for Fc-OPG in postmenopausal women
- Probability of technical success assessment using EPO PK/PD model
- Evaluate combination chemotherapy regimens with a QSP model characterizing MAP kinase signalling in colorectal cancer
- Sensitivity analysis and parameter optimization in a PBPK model characterizing drug-drug interaction between HMG-CoA reductase inhibitors and cyclosporine
- Discussion and summary